ASH-SIE Abstract Achievement Award Recipients
The following individuals received the ASH-SIE Abstract Achievement Award, which is part of the National Partner Society Abstract Achievement Awards program.
2025 Recipients
Simona Maria Di Modica
IRCCS San Raffaele Scientific Institute
Abstract Title: Tfr2-mediated erythropoiesis expansion controls systemic glucose homeostasis by modulating erythroid metabolic demand
Marcello Turi
Candiolo Cancer Institute - Fondazione del Piemonte per L'Oncologia – IRCCS
The B2M–LILRB1 axis as a novel myeloid immune checkpoint and therapeutic target in multiple myeloma
2024 Recipients
Luca Lanino, MD
IRCCS Humanitas Research Hospital
A Molecular-Based Ecosystem to Improve Personalized Medicine in Patients with Chronic Myelomonocytic Leukemia (CMML)
Enrica Federti
University of Verona
pkm2 Binds to the Regulatory Regions of Gata-1 and stat5 in β-Thalassemic Mouse Erythroblasts
2023 Recipients
Enrico Attardi, MD
University of Rome Tor Vergata
Unraveling the Impact of 2022 Classifications on Secondary Acute Myeloid Leukemia: Assessing the True Qualification Power of Diagnostic Qualifiers
Luca Lanino, MD
IRCCS
Molecular Classification of Chronic Myelomonocytic Leukemia: Results of the Analysis of an International Cohort of 2,471 Patients
2022 Recipients
Laura Notarfranchi, MD
University of Parma
Ultra-Sensitive Assessment of Measurable Residual Disease (MRD) in Peripheral Blood (PB) of Multiple Myeloma (MM) Patients Using Bloodflow
Giovanni Marconi, MD
IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori “Dino Amadori”(IRST),
Gimema AML1718 Part 1: Planned Interim Analysis of a Safety Run-in and Phase 2 Open-Label Study of Venetoclax, Fludarabine, Idarubicin and Cytarabine (V-FLAI) in the Induction Therapy of Non Low-Risk Acute Myeloid Leukemia
2021 Recipients
Annamaria Aprile, PhD
IRCCS San Raffaele Scientific Institute
Inhibition of Fibroblast Growth Factor-23 (FGF-23) Rescues Bone and Hematopoietic Stem Cell Niche Defects in Beta-Thalassemia, Uncovering the Missing Link between Hematopoiesis and Bone
Abstract #572
Enrica Federti, PhD
University of Verona
Nrf2 Plays a Key Role in Iron-Overload Cardiomyopathy
Abstract #3068
2020 Recipients
Luca Bertamini, MD
GIMEMA
Poor Prognosis of Multiple Myeloma Predicted By High Levels of Circulating Plasma Cells Is Independent from Other High-Risk Features but Is Modulated By the Achievement of Minimal Residual Disease Negativity
Abstract #720
Raffaele Palmieri, MD
University of Rome Tor Vergata
Validation of ELN2017 Risk Stratification in a Post-Hoc Analysis of the Prospective Biomarker-Based Gimema AML1310 Protocol
Abstract #392
2019 Recipients
Pier Edoardo Rovatti, MD
IRCCS San Raffaele Scientific Institute
Exploiting an Anti-CD3/CD33 Bispecific Antibody to Redirect Donor T Cells Against HLA Loss Leukemia Relapses
Abstract #513
Chiara Magnanim, PhD
IRCCS San Raffaele Scientific Institute
Donor-Derived CD19 CAR Cytokine Induced Killer (CIK) Cells Engineered with Sleeping Beauty Transposon for Relapsed B-Cell Acute Lymphoblastic Leukemia (B-ALL)
Abstract #200
2018 Recipients
Mariateresa Pettinato, MSc
IRCCS San Raffaele Scientific Institute
Inhibiting the Immunophilin FKBP12: A Potential Therapeutic Approach to Iron Overload/Low Hepcidin Disorders
Abstract #2333
Francesco Maura
University of Milan
Whole Genome Sequencing Reveals Recurrent Structural Driver Events in Peripheral T-Cell Lymphomas Not Otherwise Specified
Abstract #109
2017 Recipients
Antonella Nai, PhD
IRCCS San Raffaele Scientific Institute
The Macrophage Nuclear Receptor Coactivator 4 Counteracts Iron-Deficiency Anemia
Abstract #224
Giorgia Federico, PhD
University of Naples Federico II
NCOA4 Links Iron Bioavailability to DNA Metabolism
Abstract #223